Title: Characteristics and disease burden of patients with eosinophilic granulomatosis with polyangiitis initiating mepolizumab in the United States.
Citation: J Clin Rheumatol
2023;29:381–387.
Country: USA | Indication: EGPA
http://tago.ca/37779234
Title: Characteristics and disease burden of patients with eosinophilic granulomatosis with polyangiitis initiating mepolizumab in the United States.
Citation: J Clin Rheumatol
2023;29:381–387.
Country: USA | Indication: EGPA
Title: Characteristics and disease burden of patients with eosinophilic granulomatosis with polyangiitis initiating mepolizumab in the United States.
Citation: J Clin Rheumatol
2023;29:381–387.
Country: USA | Indication: EGPA